Explore

Trendline Trendline
Biocom Criticizes New Section 232 Tariffs on Pharmaceuticals for Potential Supply Chain Disruptions

Biocom Criticizes New Section 232 Tariffs on Pharmaceuticals for Potential Supply Chain Disruptions

Biocom Criticizes New Section 232 Tariffs on Pharmaceuticals for Potential Supply Chain Disruptions
Rapid Read Rapid Read
President Trump's Proposed 100% Drug Tariffs Could Impact Prescription Costs for Americans

President Trump's Proposed 100% Drug Tariffs Could Impact Prescription Costs for Americans

President Trump has announced a plan to impose 100% tariffs on certain imported brand-name pharmaceuticals. This move is part of a broader strategy to encourage drug manufacturers to relocate production to the United States. Companies that agree to move production domestically will face a 20% tariff during the transition period and no tariff if they also agree to lower prices to 'most favored nation' levels. The full tariff will be applied if production is not moved to the U.S. within four years. The tariffs are set to take effect on July 31 for larger companies unless they commit to price concessions and domestic manufacturing. Smaller manufacturers have until September 29 to comply. The plan excludes generic drugs, which make up about 90% of prescriptions in the U.S., due to their lower profit margins and overseas production costs.
Reuters Reuters
Bayer US head says tariffs will not affect its 2026 forecasts

Bayer US head says tariffs will not affect its 2026 forecasts

By Michael Erman NEW YORK, April 7 (Reuters) - A top Bayer AG executive said on Tuesday the German drugmaking and crop science company saw no need to adjust its 2026 forecasts because of tariffs on imported pharmaceuticals announced by the U.S. government last week.
Rapid Read Rapid Read
President Trump's Drug Tariffs Could Impact U.S. Pharmaceutical Prices

President Trump's Drug Tariffs Could Impact U.S. Pharmaceutical Prices

President Trump has announced a plan to impose 100% tariffs on certain imported brand-name drugs, a move that could significantly affect drug prices in the United States. The tariffs are part of a broader strategy to encourage domestic production and reduce reliance on foreign pharmaceuticals. Drugmakers that agree to move production to the U.S. will face a reduced tariff of 20% during the transition, with no tariff if they lower prices to 'most favored nation' levels. The full tariff will apply if production is not relocated within four years. The tariffs are set to take effect on July 31 for larger companies, with smaller manufacturers given until September 29 to comply.
Trendline Trendline
S 500 Rallies 3.4% Amid Middle East De-escalation Hopes, Tech Stocks Lead Recovery

S 500 Rallies 3.4% Amid Middle East De-escalation Hopes, Tech Stocks Lead Recovery

S 500 Rallies 3.4% Amid Middle East De-escalation Hopes, Tech Stocks Lead Recovery
Trendline Trendline
Colorado Businesses Struggle with Tariff Chaos Amidst Economic Uncertainty

Colorado Businesses Struggle with Tariff Chaos Amidst Economic Uncertainty

Colorado Businesses Struggle with Tariff Chaos Amidst Economic Uncertainty
Reuters Reuters
Bourbon demand is down and tariffs aren't helping. But distillers keep building

Bourbon demand is down and tariffs aren't helping. But distillers keep building

By Nicholas P. Brown and Emma Rumney BARDSTOWN, KY, April 7 (Reuters) - Like many whiskey distillers, Heaven Hill Brands is rolling back bourbon production this year, as demand lags.
Trendline Trendline
U.S. Administration Imposes 100% Tariffs on Branded Pharmaceutical Imports, Impacting Global Healthcare

U.S. Administration Imposes 100% Tariffs on Branded Pharmaceutical Imports, Impacting Global Healthcare

U.S. Administration Imposes 100% Tariffs on Branded Pharmaceutical Imports, Impacting Global Healthcare
Trendline Trendline
Upsher-Smith Launches Generic Ciprodex to Address Drug Market Needs

Upsher-Smith Launches Generic Ciprodex to Address Drug Market Needs

Upsher-Smith Launches Generic Ciprodex to Address Drug Market Needs
Trendline Trendline
FCC's Ban on Foreign-Made Routers Raises Market Concerns and Security Debates

FCC's Ban on Foreign-Made Routers Raises Market Concerns and Security Debates

FCC's Ban on Foreign-Made Routers Raises Market Concerns and Security Debates
Trendline Trendline
President Trump Overhauls Section 232 Tariffs, Impacting Steel, Aluminum, and Copper Imports

President Trump Overhauls Section 232 Tariffs, Impacting Steel, Aluminum, and Copper Imports

President Trump Overhauls Section 232 Tariffs, Impacting Steel, Aluminum, and Copper Imports
Trendline Trendline
Costco Navigates Tariff Challenges with Strategic Pricing Adjustments

Costco Navigates Tariff Challenges with Strategic Pricing Adjustments

Costco Navigates Tariff Challenges with Strategic Pricing Adjustments